115 related articles for article (PubMed ID: 32916418)
21. [Methylation and expression analysis of p16(INK4a) and RB genes in meningiomas].
Chen MN; Mao Q; Liu YH; Mao BY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):277-9. PubMed ID: 15192837
[TBL] [Abstract][Full Text] [Related]
22. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.
Liu Y; Pang JC; Dong S; Mao B; Poon WS; Ng HK
Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004
[TBL] [Abstract][Full Text] [Related]
23. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth.
McCutcheon IE; Friend KE; Gerdes TM; Zhang BM; Wildrick DM; Fuller GN
J Neurosurg; 2000 Feb; 92(2):306-14. PubMed ID: 10659019
[TBL] [Abstract][Full Text] [Related]
24. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges.
Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L
Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621
[TBL] [Abstract][Full Text] [Related]
25. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
26. Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.
Guyot A; Duchesne M; Robert S; Lia AS; Derouault P; Scaon E; Lemnos L; Salle H; Durand K; Labrousse F
J Neurooncol; 2019 Dec; 145(3):449-459. PubMed ID: 31729637
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence imaging of meningioma cells with somatostatin receptor ligands: an in vitro study.
Linsler S; Ketter R; Oertel J; Urbschat S
Acta Neurochir (Wien); 2019 May; 161(5):1017-1024. PubMed ID: 30877475
[TBL] [Abstract][Full Text] [Related]
28. Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells.
Pallis M; Burrows F; Ryan J; Grundy M; Seedhouse C; Abdul-Aziz A; Montero J; Letai A; Russell N
Oncotarget; 2017 Mar; 8(10):16220-16232. PubMed ID: 27092880
[TBL] [Abstract][Full Text] [Related]
29. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
[TBL] [Abstract][Full Text] [Related]
30. The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas.
Ding MH; Wang Z; Jiang L; Fu HL; Gao J; Lin XB; Zhang CL; Liu ZY; Shi YF; Qiu GZ; Ma Y; Cui DX; Hu GH; Jin WL
Biomaterials; 2015 Jul; 56():165-78. PubMed ID: 25934289
[TBL] [Abstract][Full Text] [Related]
31. Methylation markers of malignant potential in meningiomas.
Vengoechea J; Sloan AE; Chen Y; Guan X; Ostrom QT; Kerstetter A; Capella D; Cohen ML; Wolinsky Y; Devine K; Selman W; Barnett GH; Warnick RE; McPherson C; Chiocca EA; Elder JB; Barnholtz-Sloan JS
J Neurosurg; 2013 Oct; 119(4):899-906. PubMed ID: 23930849
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
33. Methylation status of TP73 in meningiomas.
Lomas J; Amiñoso C; Gonzalez-Gomez P; Eva Alonso M; Arjona D; Lopez-Marin I; de Campos JM; Isla A; Vaquero J; Gutierrez M; Sarasa JL; Josefa Bello M; Rey JA
Cancer Genet Cytogenet; 2004 Jan; 148(2):148-51. PubMed ID: 14734228
[TBL] [Abstract][Full Text] [Related]
34. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
35. Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.
Cho H; Ha SY; Park SH; Park K; Chae YS
J Korean Med Sci; 1999 Apr; 14(2):199-205. PubMed ID: 10331568
[TBL] [Abstract][Full Text] [Related]
36. Report of a Novel Case of Anaplastic Olfactory Groove Meningioma and Its Methylation Subtype.
Foo ASC; Tan DTM; Tan CL; Sahm F; von Deimling A; Yeo TT
J Neuropathol Exp Neurol; 2017 Dec; 76(12):997-999. PubMed ID: 29045680
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of alterations of the p18INK4c gene in human meningiomas.
Santarius T; Kirsch M; Nikas DC; Imitola J; Black PM
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):67-75. PubMed ID: 10736068
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.
Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Baer-Dubowska W
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1593-601. PubMed ID: 25648363
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
Johnson MD; O'Connell MJ; Pilcher W; Reeder JE
J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic changes underlie the aggressiveness of histologically benign meningiomas that recur.
San-Miguel T; Navarro L; Megías J; Muñoz-Hidalgo L; Gil-Benso R; Roldán P; López-Ginés C; Cerdá-Nicolás M
Hum Pathol; 2019 Feb; 84():105-114. PubMed ID: 30261191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
